BDBM50331421 CHEMBL1289184::N-{3-[Cyclopropyl-(1,1-dioxo-1H-1lambda*6*-benzo[d]isothiazol-3-yl)-amino]-propyl}-4-fluoro-benzamide
SMILES: Fc1ccc(cc1)C(=O)NCCCN(C1CC1)C1=NS(=O)(=O)c2ccccc12
InChI Key: InChIKey=KBFFWNVTEPJSMC-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Voltage-gated potassium channel (Homo sapiens (Human)) | BDBM50331421 (CHEMBL1289184 | N-{3-[Cyclopropyl-(1,1-dioxo-1H-1l...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.64E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Research and Development Curated by ChEMBL | Assay Description Inhibition of human voltage-gated potassium channel Kv1.3 expressed in CGE22 cells by patch clamp assay | Bioorg Med Chem Lett 20: 6983-8 (2010) Article DOI: 10.1016/j.bmcl.2010.09.132 BindingDB Entry DOI: 10.7270/Q2N58MMS | |||||||||||
More data for this Ligand-Target Pair |